Bayer to Pay $15 Million to Settle Aspirin Marketing Suit

Christie Smythe

A Bayer AG unit will pay $15 million to settle a U.S. lawsuit claiming it illegally marketed aspirin mixed with supplements.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.

Read this article on the Terminal Request a demo to learn more

You might like:
  1. iPhone Disappointment Hammers Suppliers
  2. Brothers Who Found Eminem Are Taking Part of His Music Public
  3. This Startup Is Luring Top Talent With $3 Million Pay Packages
  4. Trump Restricts or Bans Travel From Eight Countries
  5. Stocks Drop as Tech Gets Hit, Bonds Rise on Korea: Markets Wrap